Anesthesiology Doctors in Exton, PA Accepting Medicare

7 Anesthesiology doctors found. Showing 1 - 7

Mary E Starkman, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 460 Creamery Way, Exton, PA 19341 Phone: 610-594-8900    Fax: 610-594-8907

Dr. Frank P Tutterice, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 312 Trimble Ln, Exton, PA 19341 Phone: 610-524-2479    Fax: 610-524-2479

Andre O Williams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 460 Creamery Way, Ste 102, Exton, PA 19341 Phone: 610-280-0340    Fax: 610-280-0750

Perfecto C Galido Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 140 John Robert Thomas Dr, Exton, PA 19341 Phone: 610-280-9144    Fax: 877-329-2370

Dr. Sunil Alexander Chandy, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 495 Thomas Jones Way, Suite 304, Exton, PA 19341 Phone: 484-879-6508    Fax: 484-879-6509

Dr. John Kenneth Denlinger, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 460 Creamery Way, Suite 100, Exton, PA 19341 Phone: 610-594-8900    Fax: 610-594-8907

Melody Hu, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Arrandale Blvd Ste 103, Exton, PA 19341 Phone: 844-365-7246    Fax: 844-516-0080

News Archive

Chronic smokers have altered emotional reactions when exposed to negative, positive images of tobacco

What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en santé mentale de Montréal and University of Montreal.

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).

Canadian Cancer Society announces 'Feast for the Fight' fundraising event

Torontonians along parts of Yonge Street will have the chance to feel good while enjoying a night on the town with Feast for the Fight, a new fundraising event by the Canadian Cancer Society. Like a meal paired with fine wine, Feast for the Fight matches some of Toronto's finest restaurateurs with the country's leading cancer charity, culminating in a philanthropic dining experience.

GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009

GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per share, compared with $6.2 million, or $0.60 per share, for the fourth quarter of 2008. The total net loss for 2009 was $27.9 million, or $2.18 per share, compared to $22.7 million, or $2.31 per share, for 2008.

VG Life Sciences issues patent relating to treatment of IBD through CLIP-inducing agent

VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.

Read more Medical News

› Verified 5 days ago